Economic Evaluation of FDA-Approved Small Molecule Protein Kinase Inhibitors in Oncology and Non-Oncology Indications in the United States. IAJLB [Internet]. 2023 Feb. 18 [cited 2026 Oct. 16];20(1):20-51. Available from: https://iajlb.org/index.php/iajlb/article/view/157